Iceland· IS-EU/1/24/1799/002
Tauvid
A flortaucipir (18f) product containing flortaucipir (18f), registered in Iceland by Eli Lilly Nederland B.V.*. The same ATC class is registered in 7 of our 19 countries.
Checked against Icelandic Medicines Agency (Iceland) on
Informational only — not a medical device.
Where it is registered
Flortaucipir (18f) is registered in 7 of 19 countries.
Countries holding a registration under ATC V09AX07 (flortaucipir (18f)), each read from that country’s own register.
- This record: Iceland, from Icelandic Medicines Agency (Iceland)
- 5 of them publish a price we can compare per daily dose
Flortaucipir (18f) · ATC V09AX07
7 / 19 countries
- Belgiumprice
- Czechiaprice
- Finlandprice
- Icelandprice
- Ireland
- Netherlands
- Polandprice
The record
At a glance
Icelandic Medicines Agency (Iceland)- Active substance
- Flortaucipir (18F)
- Manufacturer
- Eli Lilly Nederland B.V.*
- Country
- Iceland (IS)
- ATC code
- V09AX07
- ATC class
- Flortaucipir (18F)
- Reimbursed
- Not published by this register
- Source register
- Icelandic Medicines Agency (Iceland)
- Last checked
- September 29, 2026
Packs & prices · 0
No packs listed by the register for this record.
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Flortaucipir (18f) in 7 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- CzechiaTAUVIDEli Lilly Nederland B.V., Utrecht
- NetherlandsTauvid 1.900 MBq/ml oplossing voor injectieEli Lilly Nederland B.V.
- SwedenTauvid 1900 MBq/ml Injektionsvätska, lösningEli Lilly Nederland B.V.
- BelgiumTauvid 1900 MBq/mlEli Lilly Nederland
- FinlandTauvidEli Lilly Nederland B.V
- United StatesTAUVIDEli Lilly and Company
- IrelandTauvid 800 MBq/mL solution for injectionEli Lilly Nederland B.V.
Authorised across Europe · EMA
The same active substance is authorised in 2 EEA countries. Names it is sold under:
- Liechtenstein · Tauvid
- Norway · Tauvid
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Icelandic Medicines Agency (Iceland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/f8d385cc-73af-4a27-80ac-9d39bca60f36 GET /v1/drugs/f8d385cc-73af-4a27-80ac-9d39bca60f36?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Stungulyf, lausn",
"source": "lyfjastofnun",
"atc_raw": "V09AX07",
"marketed": false,
"strength": "1900 MBq/ml",
"ma_number": "EU/1/24/1799/002",
"substance": "Flortaucipir (18F)",
"other_info": null,
"legal_status": "(R) Lyfseðilsskylt\r\n(H) Sjúkrahúsmerkt",
"ma_issued_serial": "45526"
}See everything about flortaucipir (18f).
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.